Free Trial

Strata Skin Sciences (SSKN) Competitors

Strata Skin Sciences logo
$0.0002 0.00 (0.00%)
As of 10/12/2026

SSKN vs. AFIB, UTRS, MOTS, DRTSW, and BDMDW

Should you buy Strata Skin Sciences stock or one of its competitors? Strata Skin Sciences's main competitors and comparable companies include Acutus Medical (AFIB), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Baird Medical Investment (BDMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Strata Skin Sciences compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Strata Skin Sciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acutus Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Acutus Medical has a beta of 5.71, suggesting that its stock price is 471% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

Strata Skin Sciences has a net margin of -35.64% compared to Acutus Medical's net margin of -272.74%. Acutus Medical's return on equity of -311.64% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Strata Skin Sciences -35.64%-476.73%-33.49%

Strata Skin Sciences has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Summary

Acutus Medical and Strata Skin Sciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to Minerva Surgical?

Strata Skin Sciences (NASDAQ:SSKN) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Strata Skin Sciences has higher earnings, but lower revenue than Minerva Surgical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
Minerva Surgical Neutral

Strata Skin Sciences has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

Given Minerva Surgical's higher probable upside, analysts clearly believe Minerva Surgical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Minerva Surgical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Minerva Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Minerva Surgical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Minerva Surgical N/A N/A N/A

Summary

Minerva Surgical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Strata Skin Sciences Neutral

20.1% of Motus GI shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Strata Skin Sciences has higher revenue and earnings than Motus GI. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Motus GI has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Motus GI's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

Motus GI has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Motus GI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Motus GI and Strata Skin Sciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Strata Skin Sciences (NASDAQ:SSKN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Strata Skin Sciences. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Strata Skin Sciences. Alpha Tau Medical's average media sentiment score of 0.27 beat Strata Skin Sciences' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Strata Skin Sciences Neutral

Alpha Tau Medical has higher earnings, but lower revenue than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Alpha Tau Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Alpha Tau Medical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Alpha Tau Medical beats Strata Skin Sciences on 5 of the 9 factors compared between the two stocks.

How does Strata Skin Sciences compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMDW) and Strata Skin Sciences (NASDAQ:SSKN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

In the previous week, Baird Medical Investment had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Strata Skin Sciences. Baird Medical Investment's average media sentiment score of 1.79 beat Strata Skin Sciences' score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Very Positive
Strata Skin Sciences Neutral

32.4% of Strata Skin Sciences shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Baird Medical Investment has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Baird Medical Investment's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

Baird Medical Investment has higher earnings, but lower revenue than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$24.49MN/AN/AN/AN/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Summary

Baird Medical Investment beats Strata Skin Sciences on 5 of the 9 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricStrata Skin SciencesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.58B$7.26B$13.21B
Dividend YieldN/A1.75%2.52%22.89%
P/E Ratio0.0020.86206.6619.94
Price / Sales0.0067.32562.2181.34
Price / CashN/A32.2577.1653.04
Price / Book0.005.8610.756.03
Net Income-$10.09M$146.14M$3.50B$380.34M
7 Day PerformanceN/A-0.96%-2.91%-2.34%
1 Month PerformanceN/A-3.60%-7.38%-5.31%
1 Year PerformanceN/A1.44%2.96%-2.94%

Strata Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
Strata Skin Sciences
N/A$0.00
flat
N/A-100.0%$1K$30.98MN/A120
AFIB
Acutus Medical
N/AN/AN/A-80.0%$3K$7.16MN/A85
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A174
MOTS
Motus GI
N/A$0.00
flat
N/AN/A$1K$319KN/A15
DRTSW
Alpha Tau Medical
N/A$3.87
-2.1%
N/A+984.8%$0.00N/AN/A121

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners